Dimension Therapeutics

Provider of gene therapy for rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups53 employees language dimensiontx.com

Registered entities

Innovation

6 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 140 times.

YearFilings
20171
20186
20193
20211

Investor mix

8 investors on record; lead investors include Jennison, RA Capital Management, Rock Springs Capital, Orbimed; 2 have since exited.

Investor typeCountShare
Venture capital563%
Private equity113%
Other / undisclosed225%
Coming soon